TA943: Tirzepatide for managing overweight and obesity
Anemia Workup: Baseline Hemoglobin, Ferritin, and TSAT levels to differentiate carnitine-responsive anemia from iron-deficiency anemia
Wegovy, also made by Novo Nordisk and with the same active ingredient as Ozempic, and Eli Lilly's Zepbound, with the same active ingredient as Mounjaro, are FDA-approved for weight loss
Over 52 weeks, resolution of MASH without worsening of fibrosis was achieved in 10% of the placebo group, 44% of the tirzepatide 5 mg group, 56% of the 10 mg group, and 62% of the 15 mg group
GLP-1 receptor agonists (such as semaglutide, liraglutide, or dulaglutide) represent an increasingly popular option for patients who require additional glycemic control after gastric bypass